Podcast Episodes

Back to Search
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

Episode 12

In this episode, Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for the first-line treat…

5 years, 10 months ago

Short Long
View Episode
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

Episode 11

In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in Waldenström macroglobulinemia, mantle c…

5 years, 10 months ago

Short Long
View Episode
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

Episode 9

In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on MET exon 14 testing and selecti…

5 years, 10 months ago

Short Long
View Episode
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2

Episode 10

In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on biomarking testing and the use …

5 years, 10 months ago

Short Long
View Episode
Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies
Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies

Episode 7

In this episode, Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer questions  focused on the topic of current and evolving use of im…

5 years, 10 months ago

Short Long
View Episode
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL

Episode 8

In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in CLL presented at the 2020 annual meetin…

5 years, 10 months ago

Short Long
View Episode
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond

Episode 6

In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly…

5 years, 10 months ago

Short Long
View Episode
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions

Episode 5

In this episode, George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer questions about NTRK fusion testing and TRK inhibitor the…

5 years, 10 months ago

Short Long
View Episode
Improving Outcomes for Patients With CML With TKIs: FAQ Podcast
Improving Outcomes for Patients With CML With TKIs: FAQ Podcast

Episode 4

In this episode, Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer questions focused on the optimal …

5 years, 10 months ago

Short Long
View Episode
Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions
Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions

Episode 1

In this episode, an expert medical oncology panel led by John L. Marshall, MD, with Jamie E. Chaft, MD, and Scot Niglio, MD, provides a brief overvie…

5 years, 10 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us